Refocus on Immunogenic Characteristics of Convalescent COVID-19 Challenged by Prototype SARS-CoV-2.
Vaccines (Basel)
; 11(1)2023 Jan 04.
Article
in En
| MEDLINE
| ID: mdl-36679968
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Risk_factors_studies
Language:
En
Journal:
Vaccines (Basel)
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Switzerland